Source:http://linkedlifedata.com/resource/pubmed/id/11208562
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-3-14
|
pubmed:abstractText |
To corroborate alterations in the functional responses to beta-adrenergic receptor (beta-AR) stimulation with changes in beta-AR signaling in failing cardiomyocytes, contractile and L-type Ca(2+) current responses to isoproterenol along with stimulated cAMP generation were compared among cardiomyocytes isolated from canines with tachycardia-induced heart failure or healthy hearts. The magnitude of shortening of failing cardiomyocytes was significantly depressed (by 22 +/- 4.4%) under basal conditions, and the maximal response to isoproterenol was significantly reduced (by 45 +/- 18%). Similar results were obtained when the responses in the rate of contraction and rate of relaxation to isoproterenol were considered. The L-type Ca(2+) current amplitude measured in failing cardiomyocytes under basal conditions was unchanged, but the responses to isoproterenol were significantly reduced compared with healthy cells. Isoproterenol-stimulated cAMP generation was similar in sarcolemmal membranes derived from the homogenates of failing (45 +/- 6.8) and healthy cardiomyocytes (52 +/- 8.5 pmol cAMP. mg protein(-1). min(-1)). However, stimulated cAMP generation was found to be significantly reduced when the membranes were derived from the homogenates of whole tissue (failing: 67 +/- 8.1 vs. healthy: 140 +/- 27.8 pmol cAMP. mg protein(-1). min(-1)). Total beta-AR density was not reduced in membranes derived from either whole tissue or isolated cardiomyocyte homogenates, but the beta(1)/beta(2) ratio was significantly reduced in the former (failing: 45/55 vs. healthy: 72/28) without being altered in the latter (failing: 72/28, healthy: 77/23). We thus conclude that, in tachycardia-induced heart failure, reduction in the functional responses of isolated cardiomyocytes to beta-AR stimulation may be attributed to alterations in the excitation-contraction machinery rather than to limitation of cAMP generation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-3-isobutylxanthine,
http://linkedlifedata.com/resource/pubmed/chemical/Adenylate Cyclase,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channels, L-Type,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0363-6119
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
280
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
R355-64
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11208562-1-Methyl-3-isobutylxanthine,
pubmed-meshheading:11208562-Adenylate Cyclase,
pubmed-meshheading:11208562-Animals,
pubmed-meshheading:11208562-Calcium Channels, L-Type,
pubmed-meshheading:11208562-Cell Membrane,
pubmed-meshheading:11208562-Cells, Cultured,
pubmed-meshheading:11208562-Cyclic AMP,
pubmed-meshheading:11208562-Dogs,
pubmed-meshheading:11208562-Female,
pubmed-meshheading:11208562-Heart,
pubmed-meshheading:11208562-Heart Failure,
pubmed-meshheading:11208562-Isoproterenol,
pubmed-meshheading:11208562-Male,
pubmed-meshheading:11208562-Membrane Potentials,
pubmed-meshheading:11208562-Myocardial Contraction,
pubmed-meshheading:11208562-Myocardium,
pubmed-meshheading:11208562-Norepinephrine,
pubmed-meshheading:11208562-Receptors, Adrenergic, beta,
pubmed-meshheading:11208562-Reference Values,
pubmed-meshheading:11208562-Signal Transduction,
pubmed-meshheading:11208562-Tachycardia
|
pubmed:year |
2001
|
pubmed:articleTitle |
Functional desensitization to isoproterenol without reducing cAMP production in canine failing cardiocytes.
|
pubmed:affiliation |
Département de Pharmacologie, Faculté de Médecine, Université de Montréal, Québec H3C 3J7, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|